Bringing a device to the US market is challenging. But if you’re developing a solution for patients around the world, the challenge is even bigger. Join us to hear from Krista Donaldson, CEO of D-Rev. "Brilliance," D-Rev's phototherapy device for severely jaundiced newborns, has helped doctors in 40 countries treat more than 130,000 babies. Krista will discuss how D-Rev is developing new products based on the lessons learned commercializing and scaling Brilliance.
Where & When
Second Floor "Library," Byers Hall, UCSF Mission Bay
Thursday, March 10, 2016
5:00-6:00 pm Sign-in & reception
6:00-7:00 pm Talk and Q&A
About the Speaker
Krista Donaldson, PhD, has driven innovation in product design, engineering, and international development for more than 15 years. As D-Rev’s CEO, Krista’s has led the release of Brilliance, a revolutionary technology treating neonatal jaundice, and the ReMotion prosthetic knee. Her leadership has won Krista acclaim as one of Fast Company’s Co.Design 50 Designers Shaping the Future, a TED speaker and a World Economic Forum Technology Pioneer. She has also been a Rainer Arnhold Fellow and a Pop!Tech Social Innovation Fellow.
Prior to D-Rev, Krista served as a Science & Technology Policy Fellow at American Association for the Advancement of Science, where, in the Diplomacy sector, she aided the US Department of State in economic policy and the reconstruction of Iraq’s electricity sector. Her work there earned recognition for its impact on bilateral relations. From 1998 to 2001, she worked as a design engineer and researcher with KickStart International (formerly ApproTEC) in Nairobi, Kenya. She also has worked at the product design firm IDEO.
A native of Nova Scotia, Krista holds a BE in Mechanical Engineering from Vanderbilt University as well as a MSE (Product Design), MSME and a PhD from Stanford University. Her doctoral work was among the first to focus on engineering and social entrepreneurship in less industrialized economies. Krista has taught at Kenyatta University in Nairobi, Kenya and South Africa’s University of Cape Town.